Key result
The ACE insertion/deletion polymorphism allele D was significantly associated with increased susceptibility to systemic lupus erythematosus (OR 1.25; 95% CI 1.07-1.48; P=0.004).
Why the study?
Does the ACE I/D gene polymorphism confer susceptibility to systemic lupus erythematosus or lupus nephritis?
Meta-Analysis (n=6,373)
Does the ACE I/D gene polymorphism confer susceptibility to systemic lupus erythematosus or lupus nephritis?
Odds Ratio: 1.25 (95% CI 1.07–1.48)
p-value: p=0.004
The ACE I/D polymorphism (specifically the D allele and DD genotype) is significantly associated with susceptibility to systemic lupus erythematosus, particularly in Asian populations, but not with lupus nephritis.
ACE D allele association may inform Asian SLE risk models; confirms prior candidate-gene data but leaves nephritis link and causality open.
BACKGROUND: The aim of this study was to determine whether the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism confers susceptibility to systemic lupus erythematosus (SLE)/lupus nephritis (LN). METHODS: A meta-analysis was conducted on the association between the ACE I/D polymorphism and SLE/LN (when available) using: (i) the allelic contrast; (ii) the recessive; (iii) the dominant; and (iv) the additive models. RESULTS: A total of 27 relevant comparisons meeting the inclusion criteria were identified, involving 2718 SLE patients and 3655 controls. Meta-analysis showed a significant association between SLE and the allele D in overall populations (odds ratio [OR] = 1.25, 95% CI: 1.07-1.48, P = 0.004). Stratification by ethnicity indicated a strong association between the allele D and SLE in Asians (OR = 1.36, 95% CI: 1.05-1.75, P = 0.019). Meta-analysis also showed a significant association between SLE and the DD genotype in overall populations (additive model) (OR = 1.38, 95% CI: 1.05-1.83, P = 0.022). In addition, we found significant associations between the recessive model and SLE in overall populations, Asians and Europeans (OR = 1.44, 95% CI: 1.11-1.88, P = 0.007; OR = 1.69, 95% CI: 1.07-2.68, P = 0.024; and OR = 1.31, 95% CI: 1.06-1.62, P = 0.013, respectively). With respect to the association between ACE I/D gene polymorphism and LN risk, there was no significant association in either the overall populations or subpopulations. CONCLUSION: The present study might suggest that ACE I/D polymorphism may be a genetic molecular marker to predict SLE, while this polymorphism may not correlate with LN susceptibility.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2017) conducted a meta-analysis in Systemic lupus erythematosus (SLE) and lupus nephritis (LN) (n=6,373). Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism vs. Controls was evaluated on Susceptibility to systemic lupus erythematosus (OR 1.25, 95% CI 1.07-1.48, p=0.004). The ACE insertion/deletion polymorphism allele D was significantly associated with increased susceptibility to systemic lupus erythematosus (OR 1.25; 95% CI 1.07-1.48; P=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: